Interact to see
Advertisement
Advertisement
NEMRX vs VEMIX
NEMRX vs VEMIX Comparison
Open Charts NEMRX vs VEMIX
Neuberger Berman Emerg Mkts Eq R3
Price$25.94
Change+$0.04 (+0.15%)
VolumeN/A
Net Assets228.6M
Vanguard Emerging Mkts Stock Idx Instl
Price$34.71
Change+$0.14 (+0.40%)
VolumeN/A
Net Assets138.25B
NEMRX vs VEMIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
NEMRX vs. VEMIX commentary
Oct 07, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEMRX is a Buy and VEMIX is a Buy.
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 138B vs. NEMRX (229M). VEMIX pays higher dividends than NEMRX: VEMIX (2.82) vs NEMRX (0.00). NEMRX was incepted earlier than VEMIX: NEMRX (15 years) vs VEMIX (25 years). NEMRX (2.25) is less costly to investors than VEMIX (0.09). NEMRX is a more actively managed with annual turnover of: 111.00 vs. VEMIX (8.00). NEMRX has a lower initial minimum investment than VEMIX: NEMRX (0) vs VEMIX (5000000). NEMRX annual gain was more profitable for investors over the last year : 23.45 vs. VEMIX (14.22). VEMIX return over 5 years is better than : 36.77 vs. NEMRX (28.76).
| NEMRX | VEMIX | NEMRX / VEMIX | |
| Total Expense Ratio | 1.95 | 0.09 | 2,167% |
| Annual Report Gross Expense Ratio | 2.25 | 0.09 | 2,500% |
| Fund Existence | 15 years | 25 years | - |
| Gain YTD | 33.094 | 24.347 | 136% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 229M | 138B | 0% |
| Annual Yield % from dividends | 0.00 | 2.82 | - |
| Returns for 1 year | 23.45 | 14.22 | 165% |
| Returns for 3 years | 63.67 | 57.05 | 112% |
| Returns for 5 years | 28.76 | 36.77 | 78% |
| Returns for 10 years | 81.58 | 79.62 | 102% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement